Alphapharm Pty Ltd v H Lundbeck A/S [2015] FCAFC 138
The claim, as properly construed, is to the (+)-enantiomer itself and does not import a further limitation by the requirement of isolation or purity; therefore, it is to a pharmaceutical substance per se under s 70(2)(a) of the Patents Act 1990 (Cth), and the extension of term is validly granted.
- Parties
- Appellant: Alphapharm Pty Ltd; Appellant: Apotex Pty Ltd; Appellant: Aspen Pharma Pty Ltd; Appellant: Sandoz Pty Ltd; Respondent: H Lundbeck A/S
- Jurisdiction
- Australia
- Judgment Date
- 22 September 2015
- Procedural Posture
- Appeal / Decision on Application for Leave to Appeal And, If Granted, Substantive Appeal
- Outcome
- Application for leave to appeal granted; appeal dismissed
- Legal Topics
- Patent Extension of Term, Pharmaceutical Substance Per Se, Statutory Construction, Estoppel
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Alphapharm Pty Ltd
Appellant
Apotex Pty Ltd
Appellant
Aspen Pharma Pty Ltd
Appellant
Sandoz Pty Ltd
Appellant
H Lundbeck A/S
Respondent
Procedural Posture
Appeal / Decision on Application for Leave to Appeal And, If Granted, Substantive Appeal
Legal Issues
- 1 Whether the claim to (+)-enantiomer includes a limitation of isolation or purity such that it is no longer to a pharmaceutical substance per se
- 2 Whether extension of term of the Patent should be granted under s 70(2)(a) of the Patents Act 1990 (Cth)
Ratio Decidendi
The claim, as properly construed, is to the (+)-enantiomer itself and does not import a further limitation by the requirement of isolation or purity; therefore, it is to a pharmaceutical substance per se under s 70(2)(a) of the Patents Act 1990 (Cth), and the extension of term is validly granted.
Court Disposition
Application for leave to appeal granted; appeal dismissed
Orders
- The application for leave to appeal be granted.
- The appeal be dismissed.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment